Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Shaw

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1998
Genetic polymorphism of CYP2D6 and lung cancer riskG L Shaw, R T Falk, J N Frame, et al.
British Journal of Cancer|April 12, 2014
Identification of pathologically insignificant prostate cancer is not accurate in unscreened menG L Shaw, B C Thomas, S N Dawson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Peptide amidating activity in human bronchoalveolar lavage fluidF M Scott, A M Treston, G L Shaw, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Candidate biomarkers for application as intermediate end points of lung carcinogenesisJ L Mulshine, R I Linnoila, A M Treston, et al.
Carcinogenesis|September 1, 1990
Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controlsH Sugimura, N E Caporaso, G L Shaw, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
Lung tumor resection does not affect debrisoquine metabolismG L Shaw, R T Falk, J Deslauriers, et al.
Cancer Research|November 1, 1993
Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testingG L Shaw, A F Gazdar, R Phelps, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1995
Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshopJ F Battey, P H Brown, E R Gritz, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancerG L Shaw, A F Gazdar, R Phelps, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1998
Genetic polymorphism of CYP2D6 and lung cancer riskG L Shaw, R T Falk, J N Frame, et al.
British Journal of Cancer|April 12, 2014
Identification of pathologically insignificant prostate cancer is not accurate in unscreened menG L Shaw, B C Thomas, S N Dawson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Peptide amidating activity in human bronchoalveolar lavage fluidF M Scott, A M Treston, G L Shaw, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Candidate biomarkers for application as intermediate end points of lung carcinogenesisJ L Mulshine, R I Linnoila, A M Treston, et al.
Carcinogenesis|September 1, 1990
Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controlsH Sugimura, N E Caporaso, G L Shaw, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1994
Lung tumor resection does not affect debrisoquine metabolismG L Shaw, R T Falk, J Deslauriers, et al.
Cancer Research|November 1, 1993
Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testingG L Shaw, A F Gazdar, R Phelps, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1995
Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshopJ F Battey, P H Brown, E R Gritz, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancerG L Shaw, A F Gazdar, R Phelps, et al.
Pageof 7